The store will not work correctly when cookies are disabled.
1-adamantylmethyl 5-[hydroxy(tetrahydrofuran-2-yl)amino]isoxazole-3-carboxylate
ID: ALA3746662
PubChem CID: 102336052
Max Phase: Preclinical
Molecular Formula: C19H26N2O5
Molecular Weight: 362.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(OCC12CC3CC(CC(C3)C1)C2)c1cc(N(O)C2CCCO2)on1
Standard InChI: InChI=1S/C19H26N2O5/c22-18(15-7-17(26-20-15)21(23)16-2-1-3-24-16)25-11-19-8-12-4-13(9-19)6-14(5-12)10-19/h7,12-14,16,23H,1-6,8-11H2
Standard InChI Key: ATRRNMVKSDCRIY-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
3.7345 1.5436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7345 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8300 2.8133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5893 -0.5726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5602 2.2656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5602 0.5726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1246 2.2656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1246 0.5726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2034 -0.5726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0291 0.0249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1839 1.1572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9852 0.2541 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5953 -0.0633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0132 0.3857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8712 -0.8447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9661 -2.0409 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5488 -1.5498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.3691 -0.8769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.9909 0.1494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.0923 -2.1920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5696 -2.3637 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.8478 -3.8377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5319 -4.5578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4404 -3.5288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3966 0.8398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5431 2.0308 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 1 0
3 5 1 0
4 6 1 0
5 6 1 0
7 8 1 0
3 7 1 0
2 9 1 0
6 10 1 0
10 8 1 0
8 9 1 0
6 11 1 0
11 12 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 13 2 0
15 18 1 0
18 19 1 0
18 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 1 0
13 25 1 0
25 26 2 0
25 12 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 362.43 | Molecular Weight (Monoisotopic): 362.1842 | AlogP: 3.38 | #Rotatable Bonds: 5 |
Polar Surface Area: 85.03 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.31 | CX Basic pKa: ┄ | CX LogP: 3.23 | CX LogD: 3.43 |
Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.63 | Np Likeness Score: -0.38 |
References
1. Averina EB, Vasilenko DA, Gracheva YA, Grishin YK, Radchenko EV, Burmistrov VV, Butov GM, Neganova ME, Serkova TP, Redkozubova OM, Shevtsova EF, Milaeva ER, Kuznetsova TS, Zefirov NS.. (2016) Synthesis and biological evaluation of novel 5-hydroxylaminoisoxazole derivatives as lipoxygenase inhibitors and metabolism enhancing agents., 24 (4): [PMID:26753816] [10.1016/j.bmc.2015.12.040] |